PAN-study: Pan-Cancer Early Detection Study (PAN)

CompletedOBSERVATIONAL
Enrollment

268

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

December 2, 2022

Study Completion Date

July 6, 2023

Conditions
Gastric CancerEsophageal CancerLiver Cancer
Interventions
DEVICE

ReCIVA

The ReCIVA breath sampler contains a CO2 and pressure sensor, which allows the operator to monitor the breath sampling procedure and patient comfort. Both the operator and the patient can pause or abort the breath sampling procedure within seconds by removing the mask. The time investment required from patients is approximately 15 minutes for consenting and medical history and 10 minutes per breath collection.

DEVICE

CASPER

Minimizes contamination of breath samples by external VOCs Removes need for clean air supply line

Trial Locations (1)

CB2 0QQ

Cambridge University Hospital NHS, Cambridge

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Cancer Research UK

OTHER

lead

Owlstone Ltd

INDUSTRY

NCT03756597 - PAN-study: Pan-Cancer Early Detection Study (PAN) | Biotech Hunter | Biotech Hunter